Lung Cancer
Volume 68, Issue 1 , Pages 16-19 , April 2010

Impact of malignant mesothelioma in Taiwan: A 27-year review of population-based cancer registry data

  • Lukas Jyuhn-Hsiarn Lee

      Affiliations

    • Department of Environmental and Occupational Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • Yu-Yin Chang

      Affiliations

    • Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • Jung-Der Wang

      Affiliations

    • Department of Environmental and Occupational Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author at: Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Room 719, No. 17, Xuzhou Road, Taipei 100, Taiwan. Tel.: +886 2 33668080; fax: +886 2 23224660.

Received 1 February 2009 ,Revised 1 May 2009 ,Accepted 21 May 2009.

References 

  1. King JE, Hasleton PS. The epidemiology and aetiology of malignant mesothelioma. In:  Kenneth O’Byrne K,  Valerie Rusch V editor. Malignant pleural mesothelioma. Oxford: Oxford University Press; 2006;p. 1–18
  2. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J. 1996;9:1932–1942
  3. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345:535–539
  4. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666–672
  5. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587–593
  6. Takahashi K. Asbestos-related diseases: time for technology sharing. Occup Med (Lond). 2008;58:384–385
  7. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–1603
  8. British Thoracic Society Standards of Care Committee . BTS statement on malignant mesothelioma in the UK, 2007. Thorax. 2007;62(Suppl. 2):ii1–ii19
  9. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–2644
  10. Collegium R. An appeal to delegates to the 4th conference of the parties to the Rotterdam convention re: chrysotile asbestos, endosulfan and tributyl tin. News on 27 October 2008. Available at: http://www.collegiumramazzini.org/news.asp [accessed on 01.12.08].
  11. Taiwan Cancer Registry, with summary information at the website available at http://crs.cph.ntu.edu.tw/main.php?Page=N1 [accessed on 23.04.09].
  12. Hsu C, Shen Y-C, Cheng C-C, Hong R-L, Chang C-J, Cheng A-L. Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:856–861
  13. Chen CJ, You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32:S66–S81
  14. Department of Health of Taiwan . Chinese translation version of the International Classification of Disease for Oncology. 2nd edn. World Health Organization; 1997;[June]
  15. Ministry of Economic Affairs . Mineral statistic yearbook Taiwan area, the Republic of China. Taipei: Ministry of Economic Affairs; 1962–2007;[in Chinese]
  16. Chu PC, Wang JD, Hwang JS, Chang YY. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates. Value Health. 2008;11:1102–1109
  17. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM—An Int J Med. 2007;100:97–105
  18. Hwang JS, Wang JD. Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med. 1999;18:1627–1640
  19. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001;22:91–113
  20. Lin RT, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369:844–849
  21. Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J. Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice. Value Health. 2008;11:4–12
  22. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007;45:379–387
  23. Chang HY, Wang JD, Chang JW, Chen CR, Suoo R, Wu MC. Industrial hygiene survey for asbestos-related factories in Taiwan. J Natl Public Health Assoc (R.O.C.). 1988;8:161–171[in Chinese]
  24. Chen CR, Chang HY, Suo J, Wang JD. Occupational exposure and respiratory morbidity among asbestos workers in Taiwan. J Formosan Med Assoc. 1992;91:1138–1142
  25. Chang HY, Wang JD, Chang JW, Chen CR, Wu MC. Airborne asbestos concentration in asbestos-related factories in Taiwan. J Natl Public Health Assoc (R.O.C.). 1988;8:28–35[in Chinese]
  26. Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O’Byrne KJ. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax. 2000;55:731–735
  27. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999;68:1799–1804
  28. Rushton L, Hutchings S, Brown TP. The Burden of cancer at work: estimation as the first step to prevention. Occup Environ Med. 2008;65:789–800

PII: S0169-5002(09)00314-6

doi: 10.1016/j.lungcan.2009.05.016

Lung Cancer
Volume 68, Issue 1 , Pages 16-19 , April 2010

Article Tools

* Image Usage & Resolution